PT
Autoridade da Concorrência

Case details

Print
Merger control
Case reference
Ccent/2026/29 - Stemlab / Cordvida*StamCriovitae
Acquired
Bebé Vida – Ciências para a Vida, S.A.
Description
A company that indirectly operates in the stem cell cryopreservation sector, providing services for the analysis, processing, and cryopreservation of stem cells, with its own facilities for storing umbilical cord blood and tissue, and other biological components.
Acquired
Cordvida Portugal, Lda
Description
A company that indirectly operates in the stem cell cryopreservation sector, providing services for the analysis, processing, and cryopreservation of stem cells, with its own facilities for storing umbilical cord blood and tissue, and other biological components.
Acquired
Stamcriovitae, S.A.
Description
A company that indirectly operates in the stem cell cryopreservation sector, providing services for the analysis, processing, and cryopreservation of stem cells, with its own facilities for storing umbilical cord blood and tissue, and other biological components.
Acquiring
Stemlab, S.A.
Description
A company operating in the stem cell cryopreservation sector, providing analysis, processing, and cryopreservation services for stem cells, with its own facilities for storing umbilical cord blood and tissue and other biological components, using the registered trademark Crioestaminal.
Sector
Activity (NACE)
Applicable legislation
Notification thresholds
Type of merger
Cooperation with sector regulators
Status
Ongoing
Type of Investigation
AdC’s decision
Case description

The merger operation consists of Stemlab, S.A. (“Stemlab”) acquiring exclusive control over Cordvida Portugal, Lda. (“Cordvida”) and its subsidiary, Stamcriovitae, Ltda. (“Stamcriovitae”), which, in turn, owns Bebévida – Ciências para a Vida, S.A..
Timeline
2026-05-11
Stemlab notifies the acquisition of exclusive control over Cordvida and StamCriovitae
Click here to see your activities